Aortic Wall Mechanics and Composition in a Transgenic Mouse Model of Marfan Syndrome

In Marfan syndrome, mutations of the fibrillin gene (FBN1) lead to aneurysm of the thoracic aorta, making the aortic wall more susceptible to dissection, but the precise sequence of events underlying aneurysm formation is unknown. We used a rodent model of Marfan syndrome, the mgR/mgR mouse (with mgR: hypomorphic FBN1 mutation), which underexpresses FBN1, to distinguish between a defect in the early formation of elastic fibers and the later disruption of elastic fibers. The content of desmosine plus isodesmosine was used as an index of early elastogenesis; disruption of elastic fibers was analyzed by histomorphometry. Because disruption of the medial elastic fibers may produce aortic stiffening, so amplifying the aneurysmal process, we measured thoracoabdominal pulse wave velocity as an indicator of aortic wall stiffness. Both mgR/mgR and wild-type (C57BL/6J-129SV) strains were normotensive, and wall stress was not significantly modified because the increase in internal diameter (0.80±0.06 vs 0.63±0.03 mm in wild type, P <0.05) was accompanied by increased medial cross-sectional area. The aortic wall stiffened (4-fold increase in the elastic modulus-to-wall stress ratio). Desmosine content was not modified (mgR/mgR 432±31 vs wild type 492±42 &mgr;g/mg wet weight, P >0.05). Elastic fibers showed severe fragmentation: the percentage of the media occupied by elastic fibers was 18±3% in mgR/mgR mice vs 30±1% in wild-type mice, with the number of elastic segments being 1.9±0.2 vs 1.4±0.1×10−6/mm2 in the wild type (both P <0.05). In conclusion, underexpression of FBN1 in mice leads to severe elastic network fragmentation but no change in cross-linking, together with aortic dilatation. This result suggests that fragmentation of the medial elastic network and not a defect in early elastogenesis is 1 of the determinants of aortic dilatation in Marfan syndrome.

[1]  H. Dietz,et al.  Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome , 1997, Nature Genetics.

[2]  J. Atkinson,et al.  Measurement of desmosine and isodesmosine by capillary zone electrophoresis , 1995 .

[3]  R. Mecham,et al.  Elastic Fiber Structure and Assembly , 1994 .

[4]  W H Baker,et al.  Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. , 1984, Archives of surgery.

[5]  H. Dietz,et al.  Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Boutouyrie,et al.  Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. , 1999, Circulation.

[7]  R. E. Neuman,et al.  The determination of collagen and elastin in tissues. , 1950, The Journal of biological chemistry.

[8]  H. Dietz,et al.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. , 1995, Human molecular genetics.

[9]  J. Atkinson Vieillissement de l'élastine de la matrice extracellulaire artérielle: étiologie et conséquences. , 1998 .

[10]  J. Atkinson,et al.  The consequences of aortic calcium overload following vitamin D3 plus nicotine treatment in young rats. , 1991, Journal of hypertension.

[11]  C. Wooley,et al.  The Marfan syndrome: abnormal aortic elastic properties. , 1991, Journal of the American College of Cardiology.

[12]  R. Jeremy,et al.  Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. , 1994, The American journal of cardiology.

[13]  H. Dietz,et al.  Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. , 1993, Genomics.

[14]  J. Atkinson,et al.  Calcification of medial elastic fibers and aortic elasticity. , 1997, Hypertension.

[15]  A. Rovick,et al.  Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries. , 1969, The American journal of physiology.

[16]  H. Dietz,et al.  Marfan's syndrome and other microfibrillar diseases. , 1994, Advances in human genetics.

[17]  M. Cowan,et al.  American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.

[18]  R. Mecham,et al.  Extracellular matrix assembly and structure , 1994 .

[19]  J. Atkinson [Aging of arterial extracellular matrix elastin: etiology and consequences]. , 1998, Pathologie-biologie.

[20]  C. Duvivier,et al.  Vasodilators, aortic elasticity, and ventricular end-systolic stress in nonanesthetized unrestrained rats. , 1997, Hypertension.

[21]  R. E. Luna,et al.  Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. , 1998, Circulation.

[22]  J. Atkinson,et al.  Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. , 1999, Hypertension.

[23]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.